These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8251924)

  • 1. Cell biology of CML--a model linking the chronic and terminal phases.
    Gordon MY
    Leuk Lymphoma; 1993; 11 Suppl 1():93-100. PubMed ID: 8251924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
    Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
    Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell biology of CML cells.
    Gordon MY; Dazzi F; Marley SB; Lewis JL; Nguyen D; Grand FH; Davidson RJ; Goldman JM
    Leukemia; 1999 Apr; 13 Suppl 1():S65-71. PubMed ID: 10232368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of normal and neoplastic stem cells in CML.
    Eaves C; Udomsakdi C; Cashman J; Barnett M; Eaves A
    Leuk Lymphoma; 1993; 11 Suppl 1():245-53. PubMed ID: 8251904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.
    Diaz-Blanco E; Bruns I; Neumann F; Fischer JC; Graef T; Rosskopf M; Brors B; Pechtel S; Bork S; Koch A; Baer A; Rohr UP; Kobbe G; von Haeseler A; Gattermann N; Haas R; Kronenwett R
    Leukemia; 2007 Mar; 21(3):494-504. PubMed ID: 17252012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TGF-beta type II receptor in chronic myeloid leukemia: analysis of microsatellite regions and gene expression.
    Rooke HM; Vitas MR; Crosier PS; Crosier KE
    Leukemia; 1999 Apr; 13(4):535-41. PubMed ID: 10214859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemia.
    Spencer A; Vulliamy T; Kaeda J; Goldman JM; Melo JV
    Leukemia; 1997 Feb; 11(2):195-201. PubMed ID: 9009080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of some studies of chronic myelogenous leukemia: biological-clinical observations and viewing the disease as a chaotic system.
    Preisler H; Raza A
    Leuk Lymphoma; 1993; 11 Suppl 1():145-50. PubMed ID: 8251888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.
    Verstegen MM; Cornelissen JJ; Terpstra W; Wagemaker G; Wognum AW
    Leukemia; 1999 Apr; 13(4):618-28. PubMed ID: 10214871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic myeloid leukemia stem cells.
    Jamieson CH
    Hematology Am Soc Hematol Educ Program; 2008; ():436-42. PubMed ID: 19074122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology.
    Dazzi F; Capelli D; Hasserjian R; Cotter F; Corbo M; Poletti A; Chinswangwatanakul W; Goldman JM; Gordon MY
    Blood; 1998 Aug; 92(4):1390-6. PubMed ID: 9694728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.
    Jiang Q; Crews LA; Barrett CL; Chun HJ; Court AC; Isquith JM; Zipeto MA; Goff DJ; Minden M; Sadarangani A; Rusert JM; Dao KH; Morris SR; Goldstein LS; Marra MA; Frazer KA; Jamieson CH
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):1041-6. PubMed ID: 23275297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression in a murine model of bcr/abl leukemogenesis.
    van Etten RA
    Leuk Lymphoma; 1993; 11 Suppl 1():239-42. PubMed ID: 8251903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
    Schultheis B; Pasternak G; Hehlmann R
    Folia Biol (Praha); 2000; 46(6):256-63. PubMed ID: 11140859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.
    Holm F; Hellqvist E; Mason CN; Ali SA; Delos-Santos N; Barrett CL; Chun HJ; Minden MD; Moore RA; Marra MA; Runza V; Frazer KA; Sadarangani A; Jamieson CH
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15444-9. PubMed ID: 26621726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cell-free retroviral vector preparations for transduction of cells from the marrow of chronic phase and blast crisis chronic myelogenous leukemia patients and from normal individuals.
    Etkin M; Filaccio M; Ellerson D; Suh SP; Claxton D; Gaozza E; Brenner M; Moen R; Belmont J; Moore KA
    Hum Gene Ther; 1992 Apr; 3(2):137-45. PubMed ID: 1391033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-targeted specific inhibition of chronic myeloid leukemia cell growth by BCR-ABL antisense oligodeoxynucleotides.
    Skórski T; Szczylik C; Malaguarnera L; Calabretta B
    Folia Histochem Cytobiol; 1991; 29(3):85-9. PubMed ID: 1794439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization (FISH) detection of trisomy 8 in myeloid cells in chronic myeloid leukemia (CML): a study of archival blood and bone marrow smears.
    Nguyen PL; Arthur DC; Litz CE; Brunning RD
    Leukemia; 1994 Oct; 8(10):1654-62. PubMed ID: 7934161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myelogenous leukemia: mechanisms underlying disease progression.
    Shet AS; Jahagirdar BN; Verfaillie CM
    Leukemia; 2002 Aug; 16(8):1402-11. PubMed ID: 12145676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.